Breaking News

Molecule discovery holds promise for gene therapies for psoriasis

Scientists at the University of Birmingham have discovered a protein that could hold the key to novel gene therapies for skin problems including ps...

Global dermatology market set to reach US$33.7bn by 2022, despite patent expiries

Growth will be driven by a strong late-stage pipeline, which includes several highly valuable targeted therapies

Allergan acquires Topokine Therapeutics to focus on non-invasive fat reduction programme

Acquisition adds to Allergan's robust mid-to-late stage pipeline and reinforces its leadership in aesthetics innovation

Animal-free approach to metabolism studies

For assessing the effect of candidate drugs and consumer use chemicals in human skin

Researchers invent novel microneedle patch

National University of Singapore research team develops simple technique for faster and more effective delivery of painkiller and collagen

Venn Life Sciences acquires trading assets of Evocutis

Including intellectual property rights to Labskin and anti-acne compound SYN1113

Merz Pharma acquires Swiss dermatology company Neocutis

Will strengthen its aesthetics business, and particularly its business in the US

Evocutis and Bradford University Collaborate on pigmented LabSkin

Aim to discover improved ways of investigating common pigment-related skin conditions